Metabolic acidosis in patients with chronic kidney disease (CKD) is associated with increased risk for death, investigators reported at the Kidney Week 2020 Reimagined virtual
COVID-19 is associated with a high death rate among patients on maintenance dialysis, researchers concluded in a presentation at the American Society of Nephrology’s Kidney
In September 2020, the Centers for Medicare & Medicaid Services (CMS) and its Innovation Center (CMMI) finalized the End-Stage Renal Disease (ESRD) Treatment Choices (ETC)
A recent article in The New England Journal of Medicine emphasizes the ethical importance of giving well-educated patients true choices when it comes to management
A Statement by Anju Yadav, MD, FASN, – an assistant professor of nephrology at Thomas Jefferson University Hospital, Philadelphia. The increasing prevalence of type 2
A statement by Wei Ling Lau, MD, FASN, – affiliated with the Division of Nephrology, Department of Medicine, University of California, Irvine, Orange, CA. The
Results from 2 large clinical trials of sodium glucose cotransporter 2 (SGLT2) inhibitors presented at the European Society of Cardiology (ESC) Congress 2020 show that
A researcher who has spent 20 years investigating proteinuria causes and treatments will deliver the Michelle P. Winn, MD, Endowed Lectureship on “Drug Targeting of
Nobel Prize winner Sir Peter John Ratcliffe will present the Homer W. Smith Award lecture on Friday, Oct. 23 2020 at the ASN Kidney Week-
A researcher who has spent 20 years investigating proteinuria causes and treatments will deliver the Michelle P. Winn, MD, Endowed Lectureship on “Drug Targeting of